Opinions will waver, change and fluctuate over the coming months as the regime tries to avoid shooting itself further in the foot in the harsh times ahead and
Last year started out hopeful with the emergence of COVID-19 vaccines, but quickly proved to be a challenging year for governments and communities worldwide.
In places with low vaccination rates, Covid-19 has the chance to linger, and variants develop and travel. Without global vaccine equity, this entirely predictable pattern will repeat
An infectious disease physician explains why these options are badly needed Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help